Showing results (4911-4920 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 25, 2012
Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 studyDaniel Castellano, Emilio Bajetta, Ashok Panneerselvam, et al.
The Oncologist|February 14, 2013
High-resolution computed tomography findings for patients with drug-induced pulmonary toxicity, with special reference to hypersensitivity pneumonitis-like patterns in gemcitabine-induced casesMasaki Tamura, Takeshi Saraya, Masachika Fujiwara, et al.
The Oncologist|February 14, 2013
Factors associated with fatigue after surgery in women with early-stage invasive breast cancerChristine Rotonda, Francis Guillemin, Franck Bonnetain, et al.
The Oncologist|January 10, 2013
Hand-Schüller-Christian disease and Erdheim-Chester disease: coexistence and discrepancyJun Yin, Feng Zhang, Huizhen Zhang, et al.
The Oncologist|January 10, 2013
Nutrient restriction and radiation therapy for cancer treatment: when less is moreColin E Champ, Renato Baserga, Mark V Mishra, et al.
The Oncologist|January 10, 2013
The role of palliative surgery in gynecologic cancer casesJoanie Mayer Hope, Bhavana Pothuri
The Oncologist|February 28, 2013
A review of breast cancer care and outcomes in Latin AmericaNahila Justo, Nils Wilking, Bengt Jönsson, et al.
The Oncologist|February 28, 2013
Induction chemotherapy for locoregionally advanced head and neck cancer: past, present, future?Glenn J Hanna, Robert I Haddad, Jochen H Lorch
The Oncologist|February 28, 2013
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901Toshiyuki Harada, Satoshi Oizumi, Kenichiro Ito, et al.
The Oncologist|March 5, 2013
Analysis of dermatologic events in vemurafenib-treated patients with melanomaMario E Lacouture, Madeleine Duvic, Axel Hauschild, et al.
Pageof 571